New-born baby in Bohol dies from COVID-19 | Inquirer News

New-born baby in Bohol dies from COVID-19

By: - Correspondent / @leoudtohanINQ
/ 05:07 PM February 12, 2021

The town of Maribojoc in Bohol province recorded one fatality, an infant who died of complications caused by COVID-19. (Leo Udtohan/Inquirer Visayas)

TAGBILARAN CITY –– A newly born baby succumbed to the coronavirus disease (COVID-19), the youngest person to die of the disease in Bohol province.

Dr. Cesar Tomas Lopez, spokesperson of the Bohol Inter-Agency Task Force (BIATF), said the infant, whose parents came from Maribojoc town, was born prematurely at a private hospital in Tagbilaran.

Article continues after this advertisement

Lopez said the infant developed “respiratory distress” after birth.

FEATURED STORIES

“It died after four days from birth,” he said.

The infant was the 20th COVID-19 fatality in the province.

Article continues after this advertisement

As of Friday, Bohol has 959 COVID-19 cases with 827 recoveries and 20 deaths. It has 112 active cases.

LZB
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: baby, Bohol, Coronavirus, COVID-19, Philippine news updates, Regions

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.